|
|
Substance Name: Tiaprofenic acid [INN:BAN:DCF:JAN]
RN: 33005-95-7
UNII: 1LS1T6R34C
InChIKey: GUHPRPJDBZHYCJ-UHFFFAOYSA-N
Molecular Formula
- C14-H12-O3-S
Molecular Weight
- 260.312
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Drug / Therapeutic Agent
- Human Data
- Peripheral Nervous System Agents
- Reproductive Effect
- Sensory System Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Tiaprofenic acid
- Tiaprofenic acid [INN:BAN:DCF:JAN]
Synonyms
- 2-(5-Benzyl-2-thienyl)propionsaeure
- 5-18-08-00405 (Beilstein Handbook Reference)
- 5-Benzoyl-alpha-methyl-2-thiopheneacetic acid
- Acide tiaprofenique
- Acide tiaprofenique [INN-French]
- Acido tiaprofenico
- Acido tiaprofenico [INN-Spanish]
- Acidum tiaprofenicum
- Acidum tiaprofenicum [INN-Latin]
- BRN 1380662
- EINECS 251-329-3
- FC 3001
- RU 15060
- Surgam
- Tiaprofenic acid
- Tiaprofensaeure
- UNII-1LS1T6R34C
Systematic Names
- 2-Thiopheneacetic acid, 5-benzoyl-alpha-methyl-
- 5-Benzoyl-alpha-methyl-2-thiopheneacetic acid
- Tiaprofenic acid
Registry Numbers
CAS Registry Number
- 33005-95-7
FDA UNII
- 1LS1T6R34C
System Generated Number
- 0033005957
Structure Descriptors
InChI
InChI=1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)InChIKey
GUHPRPJDBZHYCJ-UHFFFAOYSA-NSmiles
CC(C(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 257mg/kg/30D- (257mg/kg) | KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION KIDNEY, URETER, AND BLADDER: "INFLAMMATION, NECROSIS, OR SCARRING OF BLADDER" | Medical Journal of Australia. Vol. 160, Pg. 123, 1994. |
mouse | LD50 | intraperitoneal | 355mg/kg (355mg/kg) | United States Patent Document. Vol. #4159986, | |
mouse | LD50 | oral | 690mg/kg (690mg/kg) | BEHAVIORAL: ANTIPSYCHOTIC | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 715, 1975. |
mouse | LD50 | subcutaneous | 675mg/kg (675mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 15, Pg. 688, 1984. | |
rat | LD50 | intraperitoneal | 225mg/kg (225mg/kg) | BEHAVIORAL: ANTIPSYCHOTIC | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 715, 1975. |
rat | LD50 | oral | 181mg/kg (181mg/kg) | BEHAVIORAL: ANTIPSYCHOTIC | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 715, 1975. |
rat | LD50 | subcutaneous | 215mg/kg (215mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 15, Pg. 688, 1984. | |
women | LDLo | oral | 168mg/kg/14D- (168mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES VASCULAR: SHOCK GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE | Medical Journal of Australia. Vol. 158, Pg. 647, 1993. |
women | TDLo | oral | 16mg/kg/2D-I (16mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: WAKEFULNESS BEHAVIORAL: EXCITEMENT | Canadian Medical Association Journal. Vol. 137, Pg. 1022, 1987. |
women | TDLo | oral | 672mg/kg/7W-I (672mg/kg) | LIVER: OTHER CHANGES BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ANOREXIA (HUMAN | Lancet. Vol. 1, Pg. 803, 1986. |
women | TDLo | oral | 720mg/kg/60D- (720mg/kg) | KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION KIDNEY, URETER, AND BLADDER: "INFLAMMATION, NECROSIS, OR SCARRING OF BLADDER" | Medical Journal of Australia. Vol. 160, Pg. 123, 1994. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 96 | deg C | EXP | |
log P (octanol-water) | 2.820 | (none) | EST | |
Atmospheric OH Rate Constant | 2.45E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.